解剖病理学市场规模预计将从 2023 年的 302.2 亿美元增至 2031 年的 532.7 亿美元。预计 2023-2031 年期间市场复合年增长率将达到 7.3%。人工智能和机器学习的融合很可能成为市场未来的趋势。
解剖病理学市场分析
诊断技术(包括数字病理学、分子诊断和成像技术)的创新提高了病理学服务的准确性和效率,推动了解剖病理学市场的增长。老龄化人口更容易患上各种疾病,导致对病理学服务的需求增加,以便进行准确的诊断和治疗计划。此外,人们对健康问题的认识不断提高、有助于早期诊断的强有力的筛查计划、支持性的监管框架和有利的报销政策正在推动解剖病理学市场的增长。
解剖病理学市场概况
预计印度将在整个市场中实现最高的复合年增长率。《2020 年国家癌症登记计划报告》预测,到 2022 年印度的癌症病例将达到 1461 万。该报告还指出,到 2025 年,癌症发病率预计将比 2020 年增加 12.8%。随着癌症患病率的飙升和医疗基础设施的进步,印度政府当局正致力于为人们提供更广泛的医疗保健解决方案。根据工业和国内贸易促进部 (DPIIT) 的数据,2000 年 4 月至 2020 年 12 月,流入药品和制药行业的外国直接投资 (FDI) 总额为 177.4 亿美元。此外,公司、组织、政府等对诊断服务和现代诊断设施进行了大量投资。因此,此类对医疗保健领域的投资促进了印度解剖病理学市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
解剖病理学市场驱动因素和机遇
癌症和肾脏疾病患病率上升
解剖病理学有助于识别异常,有助于诊断疾病,例如自身免疫性疾病、肾脏和肝脏疾病以及癌症。组织病理学是解剖病理学的重要组成部分,涉及研究疾病引起的组织变化。癌症对全世界的社会产生了重大影响。癌症是导致死亡的主要原因之一,因此对全球医疗保健系统的负担正在显著增加。世界卫生组织 (WHO) 将癌症列为全球第二大死亡原因。根据世界癌症研究基金会国际发布的数据,2022 年全球新增癌症病例约 2000 万例。此外,根据世界卫生组织 (WHO) 发布的数据,2020 年全球有近 1000 万人死于癌症。美国国家卫生统计中心的数据估计,到 2024 年,美国新诊断的癌症病例可能会达到 200 万例。此外,2024 年美国可能有约 61 万人死于癌症。根据麦克米伦癌症援助组织发布的数据,英国每年约有 392,000 人被诊断出患有癌症,每年约有 167,000 人死于癌症。
由于老年人口的增加,慢性肾病的患病率正在上升。根据美国疾病控制和预防中心的数据,2023 年,美国约有 3550 万人患有慢性肾病。活检是一种解剖病理学技术,用于检测癌症和慢性肾病。由于癌症和肾病的患病率不断上升,政府机构、医疗保健提供者和机构被迫为疾病诊断和治疗计划做出贡献。因此,癌症和其他目标疾病(如自身免疫性疾病、肾脏和肝脏疾病)患病率的激增正在推动全球解剖病理学市场的增长。
个性化医疗日益受到关注,为市场带来机遇
个性化药物的设计主要考虑了个人的基因特征,以指导有关疾病预防、诊断和治疗的决策。它们为药物制造商提供了一个机会,可以开发针对对药物没有反应的患者群体或对传统医疗保健实践没有反应的患者群体的药物。有大量证据表明,药物反应的很大一部分变化取决于基因控制的因素,包括年龄、营养、环境暴露和健康状况。基因组学在个性化药物的出现中起着重要作用,因为了解患者的基因特征将有助于医生选择合适的药物。个性化药物有助于改善医疗保健,使每个患者都能得到早期诊断、风险评估和最佳治疗。
病理学家在实践中开发和实施分子和基因组测试方面发挥着重要作用。个性化药物用于治疗乳腺癌和心血管疾病等疾病。个性化抗癌药物比其他类型的治疗副作用更少、更不严重,因为它们是为更具体的行动而设计的。此外,随着研究和临床研究的不断进展,个性化药物可能会发挥更大的潜力来改善患者护理的质量。因此,对个性化药物的日益关注预计将推动解剖病理学市场的增长。
解剖病理学市场报告细分分析
有助于得出解剖病理学市场分析的关键部分是产品和服务、应用程序和最终用户。
- 根据产品和服务,解剖病理学市场细分为仪器、耗材和服务。服务部分进一步分为组织病理学和细胞病理学。仪器部分进一步分为切片机和低温恒温器、自动染色机、组织处理器等。仪器部分在 2023 年占据了最大的市场份额。
- 根据应用,市场细分为疾病诊断、药物发现和开发等。疾病诊断领域在 2023 年占据了最大的市场份额。
- 根据最终用户,解剖病理学市场分为医院、研究实验室、诊断实验室和其他。医院部门在 2023 年占据了最大的市场份额。
解剖病理学市场份额按地区分析
解剖病理学市场报告的地理范围主要分为五个区域:北美、亚太地区、欧洲、南美和中美以及中东和非洲。2023 年,北美占据了市场主导地位。该地区市场的增长归因于癌症患病率的不断上升、政府对癌症患者筛查的举措不断增加、对有效疾病诊断的日益关注以及对先进医疗保健系统的需求激增。此外,市场参与者加大研发力度,再加上产品发布,可能会在预测期内推动北美解剖病理学市场的增长。在美国解剖病理学市场运营的参与者不断专注于开发用于病理程序的创新和便捷的仪器和耗材。 2023 年 11 月,DNA 测序和基于阵列技术的全球领导者美国 Illumina Inc. 推出了 TruSight Oncology 500 ctDNA v2(板号 1 ctDNA v2),这是其分布式液体活检检测的新版本,可对血液中的循环肿瘤 DNA 进行全面的非侵入性基因组分析,补充基于组织的检测。预计亚太地区在预测期内的复合年增长率最高。
解剖病理学市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响解剖病理学市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的解剖病理学市场细分和地理位置。
- 获取解剖病理学市场的区域特定数据
解剖病理学市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 302.2亿美元 |
2031 年市场规模 | 532.7亿美元 |
全球复合年增长率(2023 - 2031) | 7.3% |
史料 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按产品和服务
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
解剖病理学市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在解剖病理学市场运营的主要公司有:
- F. 霍夫曼-罗氏有限公司
- 贝克曼库尔特公司
- 霍洛吉奇公司
- 安捷伦科技公司
- BioGenex 实验室公司
- 戴帕斯公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取解剖病理学市场顶级关键参与者概述
解剖病理学市场新闻和最新发展
解剖病理学市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了市场的一些发展情况:
- 安捷伦科技公司与领先的全玻片成像系统供应商滨松光子株式会社合作。此次合作涉及将滨松的 NanoZoomer 系列(包括 S360MD 玻片扫描仪系统)整合到安捷伦的数字病理学解决方案中。NanoZoomer 玻片扫描仪系统通过高速扫描将玻片转换为高分辨率数字数据,完善了安捷伦提供的开放且不可知的数字病理学工作流程,旨在加速精准医疗的突破。(来源:安捷伦科技公司,公司网站,2023 年 3 月)
- PHC Corporation 的子公司 Epredia 和开发突破性癌症检测和分层技术的公司 NovaScan, Inc. 宣布签署意向书,签署 MarginScan 的美国独家商业分销协议,MarginScan 是一种医疗设备,可帮助医生实时检测非黑色素瘤皮肤癌。Epredia 已与 Avantik 合作,Avantik 是一家专门为诊断实验室提供运营支持的公司,旨在将这款新设备交到莫氏外科医生手中。(来源:PHC Corporation,公司网站,2024 年 5 月)
解剖病理学市场报告覆盖范围和交付成果
“解剖病理学市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:
- 解剖病理学市场规模及预测,涵盖全球、地区和国家层面的所有主要细分市场
- 解剖病理学市场趋势,以及驱动因素、限制因素和关键机遇等市场动态
- 详细的 PEST 和 SWOT 分析
- 解剖病理学市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及解剖病理学市场的最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The anatomic pathology market value is expected to reach US$ 53.27 billion by 2031.
The market is expected to register a CAGR of 7.3% during 2023–2031.
The services segment dominated the global anatomic pathology market and held the largest revenue share of 40.04% in 2021.
F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, BioGenex Laboratories Inc, Diapath S.p.A., Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the key players in the market.
The integration of artificial intelligence and machine learning is expected to be a prime trend in the market in the coming years.
North America dominated the market in 2023.
The increase in the prevalence of cancer and kidney diseases and the rise in the number of strategic initiatives are among the most significant factors fueling the market growth.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Anatomic Pathology Market
- F. Hoffmann-La Roche Ltd
- Beckman Coulter Inc
- Hologic Inc
- Agilent Technologies Inc
- BioGenex Laboratories Inc
- Diapath S.p.A.
- Bio SB
- Merck KGaA
- BD
- PHC Holdings Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.